Healthcare company Omega Healthcare Investors Inc (NYSE:OHI) stated on Tuesday its net income of USD72.2m (USD0.34 per common share) for the quarter ended 31 March 2019.
This marks a decrease in earnings when compared with net income of USD87.9m (USD0.42 per common share) for the corresponding period in 2018.
The company added the decline in net income for the quarter ended 31 March 2019 versus the prior year was primarily due to the reduction in gains on the sale of assets, an increase of costs related to the acquisition of MedEquities Realty Trust as well as an increase of of impairments
Operating revenues of USD223.7m were generated for the quarter ended 31 March 2019, up over operating revenues of USD220.2m for the same period in 2018.
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
Ridgetech reports net income of USD10.20m in fiscal year 2025
Genomma Lab Internacional announces Q2 2025 results
Sanofi finalizes acquisition of Blueprint Medicines to expand rare disease and immunology portfolio
CVS Health declares quarterly dividend USD0.665 per share
Lilly declares dividend of USD1.50 for Q3
Bavarian Nordic sells US Priority Review Voucher for USD160m
Bavarian Nordic sells US Priority Review Voucher for USD160m
FDA grants priority review to Innoviva's zoliflodacin for treatment of gonorrhea